Peer-reviewed article
Fetal Therapies and Clinical Research: Beyond Risk and Benefit
This article refers to:A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy TrialsConsidering Reprogenomics in the Ethical Future of Fetal Therapy TrialsConsents (and Contents) Under Pressure: Maintaining Space for…
This article refers to:A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy TrialsConsidering Reprogenomics in the Ethical Future of Fetal Therapy TrialsConsents (and Contents) Under Pressure: Maintaining Space for Moral Engagement in Research ProtocolsMaternal-Fetal Therapy: The (Psycho)Social DilemmaWhat Lies Beneath the Framework: The Importance of Grounding Ethical Discussions of Maternal-Fetal TherapyMultidisciplinary Ethics Review for Liminal Cases in Maternal-Fetal Surgery: A ModelRestrictions on Abortion, Social Justice and the Ethics of Research in Maternal-Fetal Therapy Trials
Related writing.
Why the Dutch Keep Pediatric Euthanasia Illegal
Pediatric euthanasia in The Netherlands has a unique legal status - it is illegal, openly practiced, and well-regulated. The most surprising part isn't the law that enabled this — it's what happened after.
Associations of Physician Perspectives, Personal Choices, and Counseling for Severe Congenital Heart Defects
OBJECTIVE: To assess whether physicians' perspectives of outcomes or personal choices are associated with prenatal counseling for termination of pregnancy (TOP) or perinatal hospice for severe congenital heart defects (CHDs). METHOD:…
Variation in the extent to which patient information leaflets describe potential benefits and harms of trial interventions: a commentary
Clinical trial participants must understand the possible risks and benefits of trial interventions before providing their informed consent to participate. The aim of this commentary is twofold: to summarize the discrepancies in the extent…
Pediatric Gender Medicine—Reply
Third, emerging evidence suggests that modulating glycosylation pathways could offer a novel therapeutic strategy for asthma management.Xie et al 5 proposed that targeting glycan recognition receptors, such as sialic acid-binding…
About the author
John D. Lantos is a pediatrician and bioethicist writing on AI in medicine, neonatal intensive care, and end-of-life decisions. His essays appear in JAMA, JAMA Pediatrics, the Hastings Center Report, the New England Journal of Medicine, and Aeon. Read more about John.